Locations:
Search IconSearch
April 21, 2020/COVID-19

Considerations for Respiratory Therapy During a SARS Pandemic

Preserving resources and prioritizing patient and caregiver safety

650×450-Repiratory-Therapist

By Umur Hatipoğlu, MD

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Respiratory therapy resources can be stretched to their limits during pandemics. Strong leadership is required to ensure judicious use of resources and implement standard practices while maintaining empathy for respiratory therapists who work at the front lines. Equally important is the dissemination of information through well-defined outlets (e.g. intranet sites, scheduled virtual meetings to improve procedures and shared new information). Managers should be visible on the floors supporting respiratory therapists with knowledge and understanding.

A scarcity of resources: Mechanical ventilators and ICU beds

All processes have bottlenecks. In the context of SARS pandemics such as COVID-19, mechanical ventilators and, consequently, ICU beds have become the bottlenecks due to the relatively high ventilator length of stay (approximately 10 days in the case of COVID-19).

Naturally, accessories such as circuits, filters and humidification devices may become scarce commodities as the number of deployed ventilators increases. Further, when hospitals are built, engineers assume an average demand for air and oxygen flow. Therefore, there is an upper limit to the number of ventilators that can be deployed that is dependent on facility specifications. Under those circumstances, battery-run ventilators with internal compressors may become useful.

High flow nasal cannula devices are preferred over noninvasive positive pressure ventilation due to the lower likelihood of aerosol generation and, thus, less disease transmission potential. Multiplex ventilation (MpV) refers to the practice of ventilating more than one patient with a single ventilator. There is a potential for markedly different ventilation and oxygenation for patients with uneven respiratory system impedances who are paired during MpV.

Advertisement

There are three critical problems that need to be addressed to improve safety during MpV:

  • Partitioning inspiratory flow to ensure appropriate tidal volumes for each patient.
  • Monitoring of tidal volumes for each patient.
  • Provision of individual PEEP. There are no human data available that inform clinical practice.

Multiplex ventilation is a last resort to temporize patients until additional mechanical ventilators become available.

Considerations for healthcare providers

Institutions should consider developing executive dashboards that provide daily updates on available invasive (ability to provide ventilation through an endotracheal tube) ventilator capacity. Noninvasive ventilators that can be adapted to invasive use could provide additional capability to meet surging demand.

Respiratory therapists are in the direct line of fire when dealing with SARS viruses. Any aerosol-generating procedure such as intubation, suction, bronchoscopy and nebulized treatments (due to the potential for inducing cough) requires donning N95 mask, goggles, gown and gloves. Controversy exists on the appropriate personal protective equipment (PPE) to be worn when taking care of intubated patients. Some argue for a simple face mask in place of an N95 mask, assuming a closed ventilator circuit with appropriate filters applied. However, the risk of circuit disconnection while working with an intubated patient is not trivial. Strong consideration should be given to wearing N95 masks while taking care of intubated patients. N95 sparing strategies, (e.g. disinfection of masks after use or reuse with careful donning and doffing) are highly recommended.

Advertisement

When respiratory therapists have documented exposure to the virus, they can continue to work unless symptomatic given the workforce shortages during pandemics. In the case of SARS-CoV-2, transmission by asymptomatic individuals has been strongly inferred from epidemiological studies. Consequently, a face mask should be worn at all times if work is continued.

The value of respiratory therapy

The discipline of respiratory therapy is a North American invention that originated in the 1940s. Respiratory therapists have become an integral part of hospitals as providers of inhaled therapy, experts in evaluating and using respiratory equipment including oxygen delivery devices, airway maintenance tools, airway clearance and reinflation devices and mechanical ventilators. At no time is the value of a seasoned respiratory therapist at the bedside appreciated more than during a SARS pandemic.

About the author

Dr. Hatipoğlu is a staff member at Cleveland Clinic’s Respiratory Institute. He also serves as the Enterprise Medical Director of Respiratory Therapy and Section Head of Respiratory Therapy, Department of Critical Care Medicine.

Advertisement

Related Articles

Stellate Ganglion Block
May 17, 2023/COVID-19
Nerve Block Shows Promise for Long COVID-Related Olfactory or Gustatory Dysfunction

Patients report improved sense of smell and taste

Covid image
April 26, 2023/COVID-19
What Long COVID Means for Rheumatologists (Video)

Clinicians who are accustomed to uncertainty can do well by patients

Covid related skin effects
April 4, 2023/COVID-19
Cutaneous Manifestations of COVID-19 in Special Populations

Unique skin changes can occur after infection or vaccine

Glucometer
February 10, 2023/COVID-19
Effects of COVID-19 on Blood Sugar and Type 2 Diabetes

Cleveland Clinic analysis suggests that obtaining care for the virus might reveal a previously undiagnosed condition

covid-19
January 13, 2023/COVID-19
Optimal Management of High Risk Immunocompromised Patients in the COVID-19 Era

As the pandemic evolves, rheumatologists must continue to be mindful of most vulnerable patients

covid-19 virus
January 12, 2023/COVID-19
Real World Experience with Tixagevimab/Cilgavimab in B-Cell-Depleted Patients

Early results suggest positive outcomes from COVID-19 PrEP treatment

Eosinophilic Fasciitis
November 29, 2022/COVID-19
New Onset Eosinophilic Fasciitis after COVID-19 Infection

Could the virus have caused the condition or triggered previously undiagnosed disease?

COVID-19 and rash
June 16, 2022/COVID-19
Common Skin Signs of COVID-19 in Adults: An Update

Five categories of cutaneous abnormalities are associated with COVID-19

Ad